Alterity Therapeutics
ATHE
24 hedge funds and large institutions have $383K invested in Alterity Therapeutics in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
100% more call options, than puts
Call options by funds: $18K | Put options by funds: $9K
20% more funds holding
Funds holding: 20 → 24 (+4)
4% more capital invested
Capital invested by funds: $368K → $383K (+$15K)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$101K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$65.6K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$28.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19K |
| 5 |
LPL Financial
San Diego,
California
|
+$8.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$48.5K |
| 2 |
CAM
Columbia Asset Management
Ann Arbor,
Michigan
|
-$35K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$20K |
| 4 |
GBA
Garrison Bradford & Associates
New York
|
-$8.44K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.83K |
ATHE Hedge Fund Activity: Q4 2015 in Review
24 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2015, worth a combined $383K — up 4.1% from $368K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ATHE positions and 4 closed out — a net gain of 4 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $101K. The largest seller was Citadel Advisors, cutting an estimated $48.5K.
- 24 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2015, up from 20 in Q3 2015.
- Funds reported $383K of Alterity Therapeutics stock for Q4 2015, up 4.1% quarter-over-quarter.
- 8 funds opened new Alterity Therapeutics positions in Q4 2015 and 4 closed out, a net change of +4 holders.
- The largest Alterity Therapeutics buyer in Q4 2015 was Morgan Stanley, an estimated $101K added.
- The largest Alterity Therapeutics seller in Q4 2015 was Citadel Advisors, an estimated $48.5K sold.
Based on aggregated 13F filings for Q4 2015.